Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer

Figure 4

Relapse-free survival outcomes based on different ACVR2B-AS1 expression levels in different subgroups. Notes: The subgroups include tumor grades G1/G2, G3/G4, stage I/II, stage III/IV, males, females, and younger and older patients.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)